These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. A systematic overview of chemotherapy effects in ovarian cancer. Högberg T; Glimelius B; Nygren P; Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940 [TBL] [Abstract][Full Text] [Related]
32. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report. Kuske RR; Perez CA; Grigsby PW; Lovett RD; Jacobs AJ; Galakatos AE; Camel HM; Kao MS Am J Clin Oncol; 1989 Dec; 12(6):467-73. PubMed ID: 2686392 [TBL] [Abstract][Full Text] [Related]
33. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
34. A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation. Grönroos M; Nieminen U; Kauppila A; Kauppila O; Saksela E; Väyrynen M Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):33-42. PubMed ID: 6376194 [TBL] [Abstract][Full Text] [Related]
35. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy. Green S; Stock RG; Greenstein AJ Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):835-40. PubMed ID: 10386640 [TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated whole abdomen irradiation following adjuvant carboplatin/taxane chemotherapy for FIGO stage III ovarian cancer : four-year outcomes. Rochet N; Lindel K; Katayama S; Schubert K; Herfarth K; Schneeweiss A; Sohn C; Harms W; Debus J Strahlenther Onkol; 2015 Jul; 191(7):582-9. PubMed ID: 25786589 [TBL] [Abstract][Full Text] [Related]
37. Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Liao Z; Strom EA; Buzdar AU; Singletary SE; Hunt K; Allen PK; McNeese MD Int J Radiat Oncol Biol Phys; 2000 Jul; 47(5):1191-200. PubMed ID: 10889372 [TBL] [Abstract][Full Text] [Related]
38. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation. Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441 [TBL] [Abstract][Full Text] [Related]
39. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study. Pisano C; Greggi S; Tambaro R; Losito S; Iodice F; Di Maio M; Ferrari E; Falanga M; Formato R; Iaffaioli VR; Pignata S Anticancer Res; 2005; 25(5):3501-5. PubMed ID: 16101169 [TBL] [Abstract][Full Text] [Related]
40. Chemoradiation for High-grade Neuroendocrine Carcinoma of the Rectum and Anal Canal. Voong KR; Rashid A; Crane CH; Minsky BD; Krishnan S; Yao JC; Wolff RA; Skibber JM; Feig BW; Chang GJ; Das P Am J Clin Oncol; 2017 Dec; 40(6):555-560. PubMed ID: 26237193 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]